In a recent study published in the Journal of Medical Virology, researchers investigated whether using nirmatrelvir during acute coronavirus disease 2019 (COVID-19) lowers the likelihood of...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, which originated in Wuhan, China in December 2019, has caused the 2019 novel coronavirus (CoV) disease (COVID-19) and...
More than 627 million people worldwide are infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the ongoing coronavirus disease 2019 (COVID-19)....
Much research has been done to control or mitigate the social and economic impact of the 2019 coronavirus disease (COVID-19) pandemic. study: Inhaled aprotinin reduces viral...
The development of an oral antiviral drug that can reduce COVID-19 hospitalization and mortality in unvaccinated high-risk individuals is nothing more than a game change, a...
recently Weekly morbidity and mortality report (MMWR) Published on the US Centers for Disease Control and Prevention (US-CDC) website, The researchers described cases of coronavirus disease...
Recent Comments